Breathe Well Live Well
|
German firm Boehringer Ingelheim's patent for asthma drug revoked
Economic Times MUMBAI: India's Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla. The patent was revoked on grounds that it lacks … |
View full post on asthma – Google News
|
German co's patent for asthma drug revoked
Times of India MUMBAI: India's Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla. The patent was revoked on grounds that it lacks … |
View full post on asthma – Google News
Business Insider |
AstraZeneca's patent on asthma drug invalidated by U.S. court
Business Insider NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District … AstraZeneca plc (ADR) Patent On Asthma Drug Declared Invalid By US Court AstraZeneca loses its US patent rights for asthma drug Pulmicort Respules |
View full post on asthma – Google News
Reuters |
AstraZeneca's patent on asthma drug invalidated by US court
Reuters NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District … Actavis launches Pulmicort Respules generic on AZ legal loss |
View full post on asthma – Google News
euronews |
AstraZeneca's patent on asthma drug invalidated by US court
Yahoo News NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District … Actavis launches Pulmicort Respules generic on AZ legal loss |
View full post on asthma – Google News
|
AstraZeneca's Kid Asthma Drug Patent Deemed Obvious
Law360 (subscription) Law360, Los Angeles (February 13, 2015, 4:49 PM ET) — A New Jersey federal judge on Friday opened the door for Sandoz Inc., Apotex Inc. and other competitors of AstraZeneca PLC to launch generic versions of its pediatric asthma medication, finding … |
View full post on asthma – Google News
The Press |
City scientists patent asthma breakthrough
The Press Wellington scientists have patented a ground-breaking vaccine for asthma. Trial results published today show the vaccine works in mice, preventing inflammation of the lungs and airways. The vaccine is a novel way of dealing with allergies which, … Wellington researchers discover new technology for asthma vaccine Asthma vaccine patented by Kiwi scientists |
View full post on asthma – Google News
Stuff.co.nz |
City scientists patent asthma breakthrough
Stuff.co.nz Wellington scientists have patented a ground-breaking vaccine for asthma. Trial results published today show the vaccine works in mice, preventing inflammation of the lungs and airways. The vaccine is a novel way of dealing with allergies which, … |
View full post on asthma – Google News
|
Teva Asthma Drug Would Infringe Mylan Patent, Judge Says
Law360 (subscription) Law360, New York (July 17, 2013, 7:18 PM ET) — A West Virginia federal judge ruled Wednesday that an asthma treatment proposed by generic drugmaker Teva Pharmaceutical USA Inc. would violate a patent covering Mylan Inc.'s Perforomist treatment. |
View full post on asthma – Google News
 IBTimes.co.uk |
AstraZeneca Loses US Patent Protection for Asthma Drug
Fox Business A patent protecting AstraZeneca's (AZN) Pulmicort Respules asthma drug in the U.S. was deemed invalid on Tuesday, paving the way for a generic version of the drug to hit store shelves. The company said on Tuesday a district court in New Jersey ruled in … AstraZeneca Loses US Patent on Asthma Drug US court blow for AstraZeneca on asthma drug Teva loses exclusivity on AstraZeneca asthma drug |
View full post on asthma – Google News